Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population ; volume:23 ; number:1 ; day:8 ; month:11 ; year:2023 ; pages:1-11 ; date:12.2023
BMC infectious diseases ; 23, Heft 1 (8.11.2023), 1-11, 12.2023
- Urheber
-
Thi Khanh, Huyen Nguyen
Cornelissen, Laura
Castanares-Zapatero, Diego
Pauw, Robby De
Cauteren, Dieter Van
Demarest, Stefaan
Drieskens, Sabine
Devleesschauwer, Brecht
Ridder, Karin De
Charafeddine, Rana
Smith, Pierre
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-023-08787-8
- URN
-
urn:nbn:de:101:1-2024012910332929512553
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thi Khanh, Huyen Nguyen
- Cornelissen, Laura
- Castanares-Zapatero, Diego
- Pauw, Robby De
- Cauteren, Dieter Van
- Demarest, Stefaan
- Drieskens, Sabine
- Devleesschauwer, Brecht
- Ridder, Karin De
- Charafeddine, Rana
- Smith, Pierre
- SpringerLink (Online service)
Ähnliche Objekte (12)
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Peptide variants of a SARS-CoV-2 neutralizing protein
Antibody cocktail effective against variants of SARS-CoV-2
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants
Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
Reducing mobility of SARS-CoV-2 variants to safeguard containment
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Peptide variants of a SARS-CoV-2 neutralizing protein
Antibody cocktail effective against variants of SARS-CoV-2
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants
Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
Reducing mobility of SARS-CoV-2 variants to safeguard containment
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Peptide variants of a SARS-CoV-2 neutralizing protein
Antibody cocktail effective against variants of SARS-CoV-2
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants
Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
Reducing mobility of SARS-CoV-2 variants to safeguard containment
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
SARS-CoV-2: phenotype, genotype, and characterization of different variants